Aligos Therapeutics Inc.
ALGS
|
|
| |
|
| Trading Volume | 15,978 |
|
|
1.13 - 0.38 |
| Market Cap Full | $ 16.2M |
Quarterly +
| 2026 | 2025 | 2024 | 2023 | |
|---|---|---|---|---|
| Q1 | - | - | 47.6% | -8.3% |
| Q2 | - | - | 2.8% | 11.1% |
| Q3 | - | - | - | -23.1% |
| Q4 | - | - | - | -17% |
Monthly +
| J | F | M | A | M | J | J | A | S | O | N | D |
| 2026 | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - | - | - | - | - |
| 2025 | |||||||||||
| - | - | - | - | - | - | - | - | - | - | - | - |
| 2024 | |||||||||||
| 3.9 | 43.5 | -0.2 | -24.1 | -21.3 | -35.9 | - | - | - | - | - | - |
| 2023 | |||||||||||
| 103.6 | -24.7 | -40.1 | 32.7 | -2.6 | -14.1 | -8.3 | -3.3 | -13.2 | -19.7 | 16.7 | -5.1 |
| 2022 | |||||||||||
| -73.1 | -24.1 | -16.1 | -41.9 | 9.8 | -6.6 | 2.5 | 0.8 | -12 | -4.6 | -4.8 | -4.7 |
| 2021 | |||||||||||
| 1.9 | 2 | -20.9 | 13.1 | 8.4 | -26.9 | -28.5 | 17 | -10.9 | 4.9 | -3.8 | -22.5 |
EPS
| 2023 | 2022 | 2021 | |
|---|---|---|---|
| Q1 | -0.5 | -0.8 | -0.7 |
| Q2 | -0.4 | -0.5 | -0.8 |
| Q3 | -0.4 | -0.4 | -0.8 |
| Q4 | 0 | -0.5 | -0.9 |
| A | -1.37 | -2.25 | -3.2 |